Within 12 weeks after surgery, the patients were randomly assigned to receive T DM1 or trastuzumab for 14 cycles
side effects from clomid CXCR3 signaling in hematopoietic cells is dispensable for the recruitment of Th1, Th17, and myeloid cells to colorectal tumors Additional file 1 Figure S1